Autism Speaks and the Autism Clinical Trials Network report that a new low dose, melt-in-your-mouth version of Fluoxetine failed to reduce repetitive behaviors in children and adolescents diagnosed with Autism. Physicians’ clinical observations that Fluoxetine controlled these behaviors spurred this research. Fluoxetine is selective serotonin reuptake inhibitor (SSRI) that is commonly referred to as a […]
Tag Archives | pediatric
McCrea delivers a comprehensive, state of the art review of mild traumatic brain injury (mTBI) and post-concussion syndrome (PCS) in about 200 pages. A succinct writing style characterizes “Mild Traumatic Brain Injury and Postconcussion Syndrome: The New Evidence Base for Diagnosis and Treatment” cover to cover.